In addition to delaying the implementation of the better-known so-called Cadillac tax on high-value health care polices, one of the other things that the Consolidated Appropriations Act of 2016 (Pub. L. 114-113), (signed into law on December 18, 2015) did was implement a two-year moratorium on the medical device excise tax imposed by Internal Revenue Code section 4191.
Because of the moratorium, the excise tax will not apply to the sale of a taxable medical device by the manufacturer, producer, or importer of the device during the period beginning on January 1, 2016, and ending on December 31, 2017.
However, like the Cadillac tax, the action taken on the Medical Device tax is not a repeal but a delay.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
